Sheffield leads the way for cervical cancer diagnosis

Have your say

Patients at Sheffield Teaching Hospitals are to benefit from the introduction of a pioneering new system that improves the detection of precancerous abnormalities of the cervix.

The trust has become the first in the country to introduce the Zedscan device, which can measure and detect tissue changes in women identified with an abnormal smear test.

The system offers real-time and more accurate detection of precancerous cells than the standard procedure for examining the cervix, enabling clinicians to make better informed decisions at a patient’s first hospital visit.

It means appropriate treatment can be started quickly, or reassurance offered to patients swiftly if the diagnosis does not show anything of concern. It also reduces unnecessary biopsies.

The technology behind the system was jointly developed at The University of Sheffield and Sheffield Teaching Hospitals following a collaboration between professors Brian Brown and John Tidy.